|
|
|
|
LEADER |
01215 am a22002413u 4500 |
001 |
81938 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Shen, Xiaoqiang
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Chemistry
|e contributor
|
100 |
1 |
0 |
|a Shen, Xiaoqiang
|e contributor
|
100 |
1 |
0 |
|a Buchwald, Stephen Leffler
|e contributor
|
700 |
1 |
0 |
|a Buchwald, Stephen Leffler
|e author
|
245 |
0 |
0 |
|a Rhodium-Catalyzed Asymmetric Intramolecular Hydroamination of Unactivated Alkenes
|
260 |
|
|
|b Wiley Blackwell,
|c 2013-11-01T15:04:16Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/81938
|
520 |
|
|
|a One for the Rh(oad): The first rhodium-catalyzed asymmetric intramolecular hydroamination of unactivated olefins was developed by using dialkylbiaryl phosphine ligands (see scheme; cod=1,5-cyclooctadiene, Cy=cyclohexyl). A variety of 2-methylpyrrolidines have been synthesized with high enantioselectivities.
|
520 |
|
|
|a National Institutes of Health (U.S.) (Grant GM46059)
|
520 |
|
|
|a Merck & Co.
|
520 |
|
|
|a Boehringer Ingelheim Pharmaceuticals
|
520 |
|
|
|a National Institutes of Health (U.S.) (GM 1S10RR13886-01)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Angewandte Chemie International Edition
|